Previous 10 | Next 10 |
Quotient Ltd (QTNT) Q2 2020 Earnings Conference Call November 04, 2019, 08:00 ET Company Participants Christopher Lindop - CFO Franz Walt - CEO & Director Conference Call Participants Brandon Couillard - Jefferies Joshua Jennings - Cowen and Company Sung Ji Nam - BTIG...
Quotient (NASDAQ: QTNT ): Q2 GAAP EPS of -$0.41 misses by $0.03 . Revenue of $7.85M (+25.6% Y/Y) beats by $1.28M . Press Release More news on: Quotient Limited, Earnings news and commentary, Healthcare stocks news,
Positive results from the initial Serological Disease Screening microarray US field trial Positive Verification and Validation data for expanded Immunohematology microarray An additional three Hypercare launch sites initiated in 2019 Successful ISO 13485 : 2016 audit of M...
JERSEY, Channel Islands, Oct. 31, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced positive preliminary US field trial data on the Initial Serological Disease Screening (SDS) Microarray. “We are very encouraged by the...
October 21, 2019 Palm Beach, FL – October 21, 2019 – Acute myeloid leukemia (AML) is an orphan’s disease. The FDA defines an orphan’s disease as a condition that affects fewer than 200,000 people nationwide. Before the passage of rare disease laws in th...
JERSEY, Channel Islands, Oct. 21, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal second quarter ended September 30, 2019, will be released before market open on Monday, Nov...
Successful Extended Immunohematology Verification and Validation data paving the way for field trials Positive customer feedback and three additional hypercare sites initiated Preliminary quarterly revenue higher than guided JERSEY, Channel Islands, Oct. 17, 2019 ...
Quotient Limited ( QTNT ) is an established, commercial-stage transfusion diagnostics company with operations based in Switzerland, Scotland, and Pennsylvania. As of 2018, the company had 72 CE marked and 63 FDA licensed reagents, which generate a steady revenue stream for QTNT. However, its b...
Quotient Limited (QTNT) Q1 2020 Results Earnings Conference Call August 05, 2019, 08:00 AM ET Company Participants Chris Lindop - Chief Financial Officer Franz Walt - Chief Executive Officer Conference Call Participants Brandon Couillard - Jefferies Josh Jennings - Cowen an...
Quotient ( QTNT ) Q1 results : Revenues: $8.2M (+3.8%). More news on: Quotient Limited, Healthcare stocks news, Earnings news and commentary, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Quotient Limited Company Name:
QTNT Stock Symbol:
NASDAQ Market:
3 Tips and Tricks For Managing Risk With Penny Stocks Risk management is an essential component of penny stock trading, as these stocks are often volatile and unpredictable. Proper risk management helps to minimize potential losses by setting strict limits on the amount of money that can be l...
3 Techniques for Day Trading Penny Stocks in 2023 Day trading penny stocks is a popular investment strategy due to its potential for high returns. The stock market can be volatile, and when done correctly, day trading penny stocks offers investors the opportunity to capitalize on quick fl...
JERSEY, Channel Islands, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (Nasdaq: QTNT) (the "Company") today announced that it has given formal notice to the Nasdaq Stock Market LLC ("Nasdaq") of its intention to voluntarily delist its ordinary shares from the Nasdaq Global Market. In order t...